Intraocular Pressure: Modulation as Treatment for Glaucoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Intraocular Pressure: Modulation as Treatment for Glaucoma

Published:2011-09 Issue:3 Volume:152 Page:340-344.e2
ISSN:0002-9394
Container-title:American Journal of Ophthalmology
language:en
Short-container-title:American Journal of Ophthalmology

Author:

Caprioli Joseph,Varma Rohit

Funder

Allergan, Inc

Pfizer, Inc

Allergan Inc

Alcon, Inc

Research to Prevent Blindness, Inc

National Eye Institute, National Institutes of Health

Genentech, Inc

Replenish, Inc

Publisher

Elsevier BV

Subject

Ophthalmology

Reference28 articles.

1. The Quality of Medical Evidence and Medical Practice;Eddy,1988

2. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma;Kass;Arch Ophthalmol,2002

3. The effectiveness of intraocular pressure reduction in the treatment of normal tension glaucoma;Am J Ophthalmol,1998

4. The Advanced Glaucoma Intervention Study (AGIS): 4. Comparison of treatment outcomes within race;Ophthalmology,1998

5. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration;Am J Ophthalmol,2000

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IL-22/IL-22RA1 Promotes Human Tenon’s Capsule Fibroblasts Proliferation and Regulates Fibrosis Through STAT3 Signaling Pathway;Journal of Ocular Pharmacology and Therapeutics;2024-07-24

2. Predicting 24-hour Intraocular Pressure Fluctuations using Machine Learning: A Retrospective Analysis;2023-09-06

3. The impact of horizontal eye movements versus intraocular pressure on optic nerve head biomechanics: A tridimensional finite element analysis study;Heliyon;2023-02

4. IL-22/IL-22RA1 promotes human Tenon’s capsule fibroblasts proliferation and regulates fibrosis through STAT3 signaling pathway;2022-08-09

5. One Month Post-operative Intraocular Pressure Cutoff Predicting the Best Outcome One Year After Trabeculectomy According to Glaucoma Scale Severity;SN Comprehensive Clinical Medicine;2022-07-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3